Radiomics in head and neck squamous cell carcinoma – a leap towards precision oncology
Immunotherapy has revolutionized head and neck squamous cell carcinoma (HNSCC) treatment, with neoadjuvant chemoimmunotherapy showing promising pathological complete response rates (36–42%). Lin et al introduce a radiomics-clinical nomogram using MRI-derived intratumoral and peritumoral features to...
Saved in:
| Main Authors: | Abhishek Mahajan, Pranjal Rai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/4/e011692.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma
by: Xiao Ling, et al.
Published: (2025-01-01) -
Radiomics in pediatric brain tumors: from images to insights
by: Pranjal Rai, et al.
Published: (2025-08-01) -
Molecular features of head and neck squamous cell carcinoma
by: G. V. Kakurina, et al.
Published: (2018-09-01) -
Clinicopathological profile of head and neck squamous cell carcinoma
by: Senjuti Dasgupta, et al.
Published: (2019-01-01) -
Author Correction: Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma
by: Xiao Ling, et al.
Published: (2025-02-01)